/ bio stocks
/ Market Analysis
Why did HCW Biologics Shares Skyrocket in Today’s Trading Session?
HCW Biologics stock surged 85.5% after announcing a breakthrough second-generation immune checkpoint inhibitor that outperformed existing cancer treatments.
August 25, 2025
Nektar Therapeutics (NKTR) Jumps 116% in Premarket After Positive Trial Results
Nektar Therapeutics stock surged 116% in premarket trading after announcing successful Phase 2b trial results for its atopic dermatitis treatment.
June 24, 2025
Back to 
